mTOR inhibition is now being explored in an attempt to overcome trastuzumab resistance caused by downregulated PTEN. However, this could, paradoxically, activate PI3K and AKT. This emphasizes the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback